Jason A. Lief
Partner | Windels Marx
William C. Baton
Partner | Saul Ewing LLPHatch-Waxman Case-Law Developments and New Jersey Practice Insights | On-Demand Webinar
Broadcast Date: Wednesday, October 23, 2024 | 12:00 pm to 1:00 pm (ET)
Navigating the balance between protecting innovation and ensuring access to affordable medications is crucial.
Join Jason A. Lief of Windels Marx and William C. Baton of Saul Ewing LLP in this CLE webcast as they delve into the intricacies of the Hatch-Waxman Act and its profound impact on the pharmaceutical industry. Designed for legal professionals, pharmaceutical executives, and anyone navigating the complex landscape of drug development, this webinar will provide invaluable insights into leveraging Hatch-Waxman strategies to safeguard intellectual property while ensuring broader access to life-saving medications.
Key Topics:
- Pleading Standards in a Hatch-Waxman Case
- How are Courts Applying Iqbal-Twombly to Hatch-Waxman Cases
- Interplay of Invalidity in PTAB IPR Proceedings and the Federal Courts
- Schrodinger’s Patents: Can a Patent be Valid and Invalid at the Same Time?
- Skinny Label Updates
- What Has Happened Since Glaxo v. Teva: Amarin v. Hikma in the Federal Circuit
- New Jersey’s Contentions Rules and How They Differ in Hatch-Waxman Cases
- Disputes Regarding Expert Reports and Contentions in New Jersey Hatch-Waxman Cases
- Early Limiting of Patent Claims in New Jersey Hatch-Waxman Cases?
Agenda:
Jason A. Lief, Partner, Windels Marx
- Pleading Standards in a Hatch-Waxman Case
- How are Courts Applying Iqbal-Twombly to Hatch-Waxman Cases
- Interplay of Invalidity in PTAB IPR Proceedings and the Federal Courts
- Schrodinger’s Patents: Can a Patent be Valid and Invalid at the Same Time?
- Skinny Label Updates
- What Has Happened Since Glaxo v. Teva: Amarin v. Hikma in the Federal Circuit
William C. Baton, Partner , Saul Ewing LLP
- New Jersey’s Contentions Rules and How They Differ in Hatch-Waxman Cases
- Disputes Regarding Expert Reports and Contentions in New Jersey Hatch-Waxman Cases
- Early Limiting of Patent Claims in New Jersey Hatch-Waxman Cases?
Who Should Attend:
- Intellectual Property Lawyers/Consultants
- Patent Lawyers
- Pharmaceutical Industry Lawyers and Executives
- Regulatory Compliance Officers
- Healthcare Providers
CLE Credit:
Course Level: Intermediate | Advance Preparation: Print and review course materials
Method of Presentation: On-Demand Webcast | Prerequisite: General knowledge of the Hatch-Waxman Act
Course Code: 1411245 | Total Credits: 1.0
CLE Credit:
CA CLE 1.00 General – Approved Until: 10/23/2026
PA CLE 1.00 General – Approved Until: 10/23/2026
VT CLE 1:00 General – Approved Until: 12/31/2025
NJ CLE 1:00 General – Credits through Reciprocity
NY CLE 1:00 Areas of Professional Practice – Credits through Reciprocity
AR CLE 1:00 General – Credits through Reciprocity
CT CLE 1:00 General – Credits through Reciprocity
NH CLE 1.00 General – Meets the requirements of NH Supreme Court Rule 53
MO CLE 1.00 General – Approved Until: 10/23/2024
GA CLE 1.00 General – Approved Until: 12/31/2024
TN CLE 1.00 General – Approved Until: 10/23/2025
WI CLE 1.00 General – Approved Until: 12/31/2025
MS CLE 1.00 General – Approved Until: 10/23/2025
Self-Apply:
AL, CO, DE, FL, ID, IN, IO, KS, KY, LA, NC, ME, MN, MT, NE, NV, NM, ND, OH, OK, OR, SC, TX, UT, VA, WA, WV, WY
If you’d like us to apply for CLE, you may opt to pay the CLE processing fee here.
No MCLE Requirements:
DC, MD, MA, MI, SD
Not Eligible for CLE:
AK, AZ, HA, IL